BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sari I, Birlik M, Gonen C, Akar S, Gurel D, Onen F, Akkoc N. Cytomegalovirus colitis in a patient with Behcet’s disease receiving tumor necrosis factor alpha inhibitory treatment. World J Gastroenterol 2008; 14(18): 2912-2914 [PMID: 18473420 DOI: 10.3748/wjg.14.2912]
URL: https://www.wjgnet.com/1007-9327/full/v14/i18/2912.htm
Number Citing Articles
1
Rasha H. Bassyouni, Reham A. Dwedar, Eman M. Ezzat, Raghda N. Marzaban, Maha Hamdy Nassr, Laila Rashid. Elevated Cytomegalovirus and Epstein-Barr virus burden in rheumatoid arthritis: A true pathogenic role or just a coincidenceThe Egyptian Rheumatologist 2019; 41(4): 255 doi: 10.1016/j.ejr.2019.03.003
2
Seo Young Kim, Daniel H. Solomon. Tumor necrosis factor blockade and the risk of viral infectionNature Reviews Rheumatology 2010; 6(3): 165 doi: 10.1038/nrrheum.2009.279
3
Raphaël André, Alexandra Opris, Félicie Costantino, Gilles Hayem, Maxime Breban. Cytomegalovirus subacute thyroiditis in a patient treated by infliximab for psoriatic arthritisJoint Bone Spine 2016; 83(1): 109 doi: 10.1016/j.jbspin.2015.06.001
4
M. J. SHALE, C. H. SEOW, C. S. COFFIN, G. G. KAPLAN, R. PANACCIONE, S. GHOSH. Review article: chronic viral infection in the anti‐tumour necrosis factor therapy era in inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics 2010; 31(1): 20 doi: 10.1111/j.1365-2036.2009.04112.x
5
Anzelika Rubina, Mihil Patel, Katie Nightingale, Martin Potts, Ceri A. Fielding, Simon Kollnberger, Betty Lau, Kristin Ladell, Kelly L. Miners, Jenna Nichols, Luis Nobre, Dawn Roberts, Terrence M. Trinca, Jason P. Twohig, Virginia-Maria Vlahava, Andrew J. Davison, David A. Price, Peter Tomasec, Gavin W. G. Wilkinson, Michael P. Weekes, Richard J. Stanton, Eddie C. Y. Wang. ADAM17 targeting by human cytomegalovirus remodels the cell surface proteome to simultaneously regulate multiple immune pathwaysProceedings of the National Academy of Sciences 2023; 120(33) doi: 10.1073/pnas.2303155120
6
Manola Comar, Serena Delbue, Loredana Lepore, Stefano Martelossi, Oriano Radillo, Luca Ronfani, Pierlanfranco D'Agaro, Pasquale Ferrante. Latent viral infections in young patients with inflammatory diseases treated with biological agents: Prevalence of JC virus genotype 2Journal of Medical Virology 2013; 85(4): 716 doi: 10.1002/jmv.23525
7
S. Domm, J. Cinatl, U. Mrowietz. The impact of treatment with tumour necrosis factor-α antagonists on the course of chronic viral infections: a review of the literatureBritish Journal of Dermatology 2008; 159(6): 1217 doi: 10.1111/j.1365-2133.2008.08851.x
8
Meyler's Side Effects of Drugs2016; : 73 doi: 10.1016/B978-0-444-53717-1.00890-8
9
Dora Y. Ho, Kyle Enriquez, Ashrit Multani. Herpesvirus Infections Potentiated by BiologicsInfectious Disease Clinics of North America 2020; 34(2): 311 doi: 10.1016/j.idc.2020.02.006
10
Cloé Comarmond, Bertrand Wechsler, Patrice Cacoub, David Saadoun. Approaches to immunosuppression in Behçet’s diseaseImmunotherapy 2013; 5(7): 743 doi: 10.2217/imt.13.66
11
Renée M. Marchioni Beery, Joshua R. Korzenik. Treatment of Inflammatory Bowel Disease with Biologics2018; : 185 doi: 10.1007/978-3-319-60276-9_12
12
Aikaterini Arida, Kalliopi Fragiadaki, Eirini Giavri, Petros P. Sfikakis. Anti-TNF Agents for Behçet's Disease: Analysis of Published Data on 369 PatientsSeminars in Arthritis and Rheumatism 2011; 41(1): 61 doi: 10.1016/j.semarthrit.2010.09.002
13
J. Correia, A. Campar, C. Ferrão, S. Silva, C. Vasconcelos. Infection and Autoimmunity2015; : 759 doi: 10.1016/B978-0-444-63269-2.00055-6
14
Justina Wei Lynn Tan, Hwee Siew Howe, Hiok Hee Chng. Ovarian Vein Thrombosis in Behçet DiseaseJCR: Journal of Clinical Rheumatology 2012; 18(2): 89 doi: 10.1097/RHU.0b013e318247c187
15
Gulen Hatemi, Hasan Yazici. Behçet’s syndrome and micro-organismsBest Practice & Research Clinical Rheumatology 2011; 25(3): 389 doi: 10.1016/j.berh.2011.05.002
16
Muhammed Sherid, Eli D. Ehrenpreis. Types of Colitis Based on HistologyDisease-a-Month 2011; 57(9): 457 doi: 10.1016/j.disamonth.2011.05.004
17
Christian Michaux, Philippe Morlat, Fabrice Bonnet. Infections à cytomégalovirus et autres viroses du groupe herpès au cours des maladies systémiquesLa Presse Médicale 2010; 39(1): 34 doi: 10.1016/j.lpm.2009.04.005
18
Moe Kato, Shin Lee, Tetsuji Morishita, Kei Fujita, Atsushi Tagami, Hiroshi Araki, Jun-ichi Sugihara. Hemophagocytic syndrome due to Epstein-Barr virus and cytomegalovirus coinfection in a patient on adalimumabJournal of Infection and Chemotherapy 2022; 28(6): 823 doi: 10.1016/j.jiac.2022.01.018
19
Ondrej Hradsky, Ivana Copova, Kristyna Zarubova, Marianna Durilova, Jiri Nevoral, Miroslav Maminak, Petr Hubacek, Jiri Bronsky. Seroprevalence of Epstein–Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel DiseaseDigestive Diseases and Sciences 2015; 60(11): 3399 doi: 10.1007/s10620-015-3764-z
20
Fatemeh Dabbagh, Afshin Borhani Haghighi, Younes Ghasemi. Behcet’s disease: from heat shock proteins to infectionsAsian Biomedicine 2014; 8(2): 139 doi: 10.5372/1905-7415.0802.274
21
R. Cavallo. The laboratory of clinical virology in monitoring patients undergoing monoclonal antibody therapyClinical Microbiology and Infection 2011; 17(12): 1781 doi: 10.1111/j.1469-0691.2011.03678.x
22
Daniel Sánchez-Cano, José Luis Callejas-Rubio, Ricardo Ruiz-Villaverde, Raquel Ríos-Fernández, Norberto Ortego-Centeno. Off-Label Uses of Anti-TNF Therapy in Three Frequent Disorders: Behçet’s Disease, Sarcoidosis, and Noninfectious UveitisMediators of Inflammation 2013; 2013: 1 doi: 10.1155/2013/286857
23
I. Marie, E. Guglielmino. Infections opportunistes non tuberculeuses au cours des traitements par les anti-TNFαLa Revue de Médecine Interne 2010; 31(5): 353 doi: 10.1016/j.revmed.2009.04.010
24
Felix Braun, Nadja Rifaie, Dieter C. Broering, Matthias Behrend. Side Effects of Drugs Annual 32 - A worldwide yearly survey of new data and trends in adverse drug reactions and interactionsSide Effects of Drugs Annual 2010; 32: 675 doi: 10.1016/S0378-6080(10)32037-X
25
M. J. Shale. The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel diseaseBritish Medical Bulletin 2009; 92(1): 61 doi: 10.1093/bmb/ldp036
26
Saied Ghorbani, Davod Javanmard, Seyed Jalal Kiani, Ahmad Tavakoli, Somayeh Sadat Moochani, Seyed Hamid Reza Monavari. No evidence of Human Cytomegalovirus infection among Behcet's PatientsIranian Journal of Medical Microbiology 2020; 14(2): 133 doi: 10.30699/ijmm.14.2.133
27
Cloé Comarmond, Bertrand Wechsler, Bahram Bodaghi, Patrice Cacoub, David Saadoun. Biotherapies in Behçet's diseaseAutoimmunity Reviews 2014; 13(7): 762 doi: 10.1016/j.autrev.2014.01.056
28
Ivan Noreña, Mario Fernández-Ruiz, José María Aguado. Viral infections in the biologic therapy eraExpert Review of Anti-infective Therapy 2018; 16(10): 781 doi: 10.1080/14787210.2018.1521270
29
Pierre Charles, Felix Ackermann, Gaelle Burdy, Olivier Blétry, Jacques Leport, Jean Emmanuel Kahn. Cytomegalovirus colitis complicating ulcerative colitis treated with adalimumabScandinavian Journal of Gastroenterology 2010; 45(4): 509 doi: 10.3109/00365520903583871
30
Haoting Zhan, Linlin Cheng, Haolong Li, Yongmei Liu, Yuan Huang, Xiaomeng Li, Songxin Yan, Yongzhe Li. Integrated analyses delineate distinctive immunological pathways and diagnostic signatures for Behcet’s disease by leveraging gene microarray dataImmunologic Research 2023; 71(6): 860 doi: 10.1007/s12026-023-09398-w
31
Raphaël André, Alexandra Opris, Félicie Costantino, Gilles Hayem, Maxime Breban. Thyroïdite subaiguë de De Quervain à cytomégalovirus chez un patient traité par infliximab pour un rhumatisme psoriasiqueRevue du Rhumatisme 2015; 82(5): 344 doi: 10.1016/j.rhum.2015.01.002
32
C. Comarmond, B. Wechsler, P. Cacoub, D. Saadoun. Traitement de la maladie de BehçetLa Revue de Médecine Interne 2014; 35(2): 126 doi: 10.1016/j.revmed.2013.12.003